This review summarizes current guideline recommendations for primary and secondary venous thromboembolism prophylaxis in cancer patients.
Answers are grounded in this paper and cite their sources.
May serve as a practical reference for VTE prophylaxis in cancer; leaves open questions on implementation and evolving evidence.
Thromboprophylaxis is underused in patients with cancer, despite the fact that malignancy is a serious risk factor for venous thromboembolism in this population. Major medical guidelines, including those published recently by the American College of Chest Physicians, the American Society of Clinical Oncology, and the National Comprehensive Cancer Network, recommend routine thromboprophylaxis for patients with cancer under certain situations. This review describes current recommendations for primary and secondary prophylaxis in patients with cancer.
No takes yet. Share an insight, caveat, or question.
Jack Ansell (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: